首页> 外国专利> THE EVALUATION METHOD FOR VALSARTAN TREATMENT OF CAD ANGINAL HYPERTENSIVE PATIENTS WITH DIASTOLIC FUNCTION DISRUPTION OF A LEFT VENTRICLE UNDER “HYPERTROPHIA” TYPE

THE EVALUATION METHOD FOR VALSARTAN TREATMENT OF CAD ANGINAL HYPERTENSIVE PATIENTS WITH DIASTOLIC FUNCTION DISRUPTION OF A LEFT VENTRICLE UNDER “HYPERTROPHIA” TYPE

机译:肥大型左室舒张功能障碍冠心病高血压患者缬沙坦的评价方法。

摘要

The evaluation method for valsartan treatment of CAD anginal hypertensive patients with diastolic function disruption of a left ventricle under “hypertrophia” type which includes comparison of patient state before and after treatment. Before valsartan treatment a patient in quiescent state is performed Doppler- echocardiography and transmitral flow shall be determined through E-Velocity measurement, after valsartan treatment an analogous study shall be performed. If Left ventricular early repletion period flow velocity is increased by 9,1 % and more in comparison with velocity before treatment then haemodynamic result and antianginal effect shall be evaluated as positive.
机译:缬沙坦治疗“肥大”型左心室舒张功能破坏的CAD心绞痛高血压患者的评估方法,包括比较治疗前后的状态。在缬沙坦治疗之前,要对处于静止状态的患者进行多普勒超声心动图检查,并应通过E-Velocity测量确定传输流量,在缬沙坦治疗后,应进行类似研究。如果左心室早期充血期的流速比治疗前增加了9.1%,则血流动力学结果和抗心绞痛作用应为阳性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号